© 1995 Oxford University Press
OTHER |
Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson—Weiss syndrome
1Departments of Pathology, University of Pittsburgh Pittsburgh, Pennsylvania 15261 2Departments of Plastic Surgery, University of Pittsburgh Pittsburgh, Pennsylvania 15261 4Departments of Oral and Maxillofacial Surgery, University of Pittsburgh Pittsburgh, Pennsylvania 15261 6Departments of Otolaryngology, University of Pittsburgh Pittsburgh, Pennsylvania 15261 7Departments of Infectious Diseases and Microbiology, University of Pittsburgh Pittsburgh, Pennsylvania 15261 5Department of Pediatric Otolaryngology Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania 15213 3Department of Plastic Surgery, Northeast Ohio Universities College of Medicine Akron, Ohio, USA
*To whom correspondence should be addressed
Received March 15, 1995; Revised May 22, 1995; Accepted May 22, 1995
Dominant mutations in the fibroblast growth factor receptor 2 (FGFR2) gene have been recently identified as causes of four phenotypically distinct craniosynostosis syndromes, including Crouzon, Jackson—Weiss, Pfeiffer, and Apert syndromes. These data suggest that the genetics of the craniosynostosis syndromes is more complex than would be expected from their simple autosomal-dominant inheritance pattern. Identical mutations in the FGFR2 gene have been reported to cause both Pfeiffer and Crouzon syndrome phenotypes. We now report the finding of a mutation in exon Illc of the FGFR2 gene in a kindred affected with Crouzon syndrome (C1043 to G; Ala344Gly) that is identical to the mutation previously associated with Jackson—Weiss syndrome. We also report finding in a Crouzon kindred a mutation in the 3' end of exon Illu (formerly referred to as exon 5, exon 7, or exon U) (A878 to C; Gln289Pro) which encodes the amino terminal portion of the lg-like III domain of the FGFR2 protein. This exon is common to both the FGFR2 and the KGFR spliceoforms of the FGFR2 gene, unlike all previously reported Crouzon mutations, which have been found only in the FGFR2 spliceoform. These findings reveal further unexpected complexity in the molecular genetics of these craniosynostosis syndromes. The data implies that second-site mutations in FGFR2 itself (outside of exon Illc) or in other genes may determine specific aspects of the phenotypes of craniosynostosis syndromes.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Fomenkov, Y.-P. Huang, O. Topaloglu, A. Brechman, M. Osada, T. Fomenkova, E. Yuriditsky, B. Trink, D. Sidransky, and E. Ratovitski p63{alpha} Mutations Lead to Aberrant Splicing of Keratinocyte Growth Factor Receptor in the Hay-Wells Syndrome J. Biol. Chem., June 20, 2003; 278(26): 23906 - 23914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Ornitz and P. J. Marie FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease Genes & Dev., June 15, 2002; 16(12): 1446 - 1465. [Full Text] [PDF]
|
|
|
|
 |
|
 P.M. Abou-Sleiman, A. Apessos, J.C. Harper, P. Serhal, and J.D.A. Delhanty Pregnancy following preimplantation genetic diagnosis for Crouzon syndrome Mol. Hum. Reprod., March 1, 2002; 8(3): 304 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Vajo, C. A. Francomano, and D. J. Wilkin The Molecular and Genetic Basis of Fibroblast Growth Factor Receptor 3 Disorders: The Achondroplasia Family of Skeletal Dysplasias, Muenke Craniosynostosis, and Crouzon Syndrome with Acanthosis Nigricans Endocr. Rev., February 1, 2000; 21(1): 23 - 39. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. Reardon, A. Smith, J. W Honour, P. Hindmarsh, D. Das, G. Rumsby, I. Nelson, S. Malcolm, L. Adès, D. Sillence, et al. Evidence for digenic inheritance in some cases of Antley-Bixler syndrome? J. Med. Genet., January 1, 2000; 37(1): 26 - 32. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. C. Robertson, A. N. Meyer, K. C. Hart, B. D. Galvin, M. K. Webster, and D. J. Donoghue Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain PNAS, April 14, 1998; 95(8): 4567 - 4572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Diehl and R. P. Erickson Genome scan for teratogen-induced clefting susceptibility loci in the mouse: Evidence of both allelic and locus heterogeneity distinguishing cleft lip and cleft palate PNAS, May 13, 1997; 94(10): 5231 - 5236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Post, J. J. Mulvihill, and G. D. Ehrlich International Genetic Workshop on Crouzon Disease and Other Craniofacial Disorders, Pittsburgh, Pa, March 10-11, 1995 Arch Otolaryngol Head Neck Surg, May 1, 1996; 122(5): 576 - 578. [Abstract] [PDF]
|
|